These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18565458)

  • 101. Hypersomnia, asterixis and cataplexy in association with orexin A-reduced hypothalamic tumor.
    Nokura K; Kanbayashi T; Ozeki T; Koga H; Zettsu T; Yamamoto H; Ozaki N; Shimizu T; Kawase T
    J Neurol; 2004 Dec; 251(12):1534-5. PubMed ID: 15645360
    [No Abstract]   [Full Text] [Related]  

  • 102. CSF hypocretin (Orexin) in neurological and psychiatric conditions.
    Ebrahim IO; Semra YK; De Lacy S; Howard RS; Kopelman MD; Williams A; Sharief MK
    J Sleep Res; 2003 Mar; 12(1):83-4. PubMed ID: 12603790
    [No Abstract]   [Full Text] [Related]  

  • 103. The emerging role of hypocretin (orexin-A) in the developing central nervous system.
    Kotagal S
    Sleep; 2012 Feb; 35(2):171-2. PubMed ID: 22294804
    [No Abstract]   [Full Text] [Related]  

  • 104. Hypocretin-1 (orexin A) levels are normal in Huntington's disease.
    Baumann CR; Hersberger M; Bassetti CL
    J Neurol; 2006 Sep; 253(9):1232-3. PubMed ID: 16598614
    [No Abstract]   [Full Text] [Related]  

  • 105. Hypersomnia caused by isolated angiitis of the CNS.
    Nakaji K; Ikeda A; Oka Y; Tomimoto H; Shimohama S; Kanbayashi T; Shibasaki H
    Intern Med; 2005 Aug; 44(8):883-5. PubMed ID: 16157993
    [TBL] [Abstract][Full Text] [Related]  

  • 106. CSF hypocretin levels in Guillain-Barré syndrome and other inflammatory neuropathies.
    Baumann CR; Bassetti CL
    Neurology; 2004 Jun; 62(12):2337; author reply 2337. PubMed ID: 15210920
    [No Abstract]   [Full Text] [Related]  

  • 107. MiRNA profiles in cerebrospinal fluid from patients with central hypersomnias.
    Holm A; Bang-Berthelsen CH; Knudsen S; Modvig S; Kornum BR; Gammeltoft S; Jennum PJ
    J Neurol Sci; 2014 Dec; 347(1-2):199-204. PubMed ID: 25451005
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Familial narcolepsy in the Lipizzaner horse: a report of three fillies born to the same sire.
    Ludvikova E; Nishino S; Sakai N; Jahn P
    Vet Q; 2012 Jun; 32(2):99-102. PubMed ID: 22889297
    [TBL] [Abstract][Full Text] [Related]  

  • 109. 2018 worldwide survey of health-care providers caring for patients with narcolepsy: WSS narcolepsy task force.
    Rosenthal L; Thorpy MJ; Nevsimalova S; Mayer G; Han F; Dauvilliers Y
    Sleep Med; 2021 Jun; 82():23-28. PubMed ID: 33873103
    [TBL] [Abstract][Full Text] [Related]  

  • 110. The hypocretin system and psychiatric disorders.
    Pizza F; Magnani M; Indrio C; Plazzi G
    Curr Psychiatry Rep; 2014 Feb; 16(2):433. PubMed ID: 24363104
    [TBL] [Abstract][Full Text] [Related]  

  • 111. In Alzheimer disease, increased wake fragmentation found in those with lower hypocretin-1.
    Friedman LF; Zeitzer JM; Lin L; Hoff D; Mignot E; Peskind ER; Yesavage JA
    Neurology; 2007 Mar; 68(10):793-4. PubMed ID: 17339595
    [No Abstract]   [Full Text] [Related]  

  • 112. Modeling sleep and neuropsychiatric disorders in zebrafish.
    Levitas-Djerbi T; Appelbaum L
    Curr Opin Neurobiol; 2017 Jun; 44():89-93. PubMed ID: 28414966
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Alzheimer disease: increased orexin level correlates with sleep disruption and cognitive decline in Alzheimer disease.
    Malkki H
    Nat Rev Neurol; 2014 Dec; 10(12):672. PubMed ID: 25348006
    [No Abstract]   [Full Text] [Related]  

  • 114. Recurrent hypersomnia in an 18-year old boy: CSF hypocretin level and MSLT findings.
    Cho JW; Kim JH
    Sleep Med; 2016 May; 21():176. PubMed ID: 26323648
    [No Abstract]   [Full Text] [Related]  

  • 115. [Sleep and neurological diseases].
    Mayer G
    Nervenarzt; 2016 Jun; 87(6):616-22. PubMed ID: 27167889
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Decreased Cerebrospinal Fluid Orexin-A (Hypocretin-1) Concentrations in Patients after Generalized Convulsive Status Epilepticus.
    Samzadeh M; Papuć E; Furtak-Niczyporuk M; Rejdak K
    J Clin Med; 2020 Oct; 9(10):. PubMed ID: 33086714
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Characteristics of hypersomnia due to inflammatory demyelinating diseases of the central nervous system.
    Ishido H; Chiba S; Takahashi H; Isa M; Ogawa Y; Kubota H; Imanishi A; Omori Y; Ono T; Tsutsui K; Han G; Kondo H; Tsuji H; Nakamagoe K; Ishii A; Tanaka K; Tamaoka A; Shimizu T; Nishino S; Miyamoto T; Kanbayashi T
    BMJ Neurol Open; 2023; 5(1):e000428. PubMed ID: 37396796
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Classification of neurological diseases using multi-dimensional CSF analysis.
    Gross CC; Schulte-Mecklenbeck A; Madireddy L; Pawlitzki M; Strippel C; Räuber S; Krämer J; Rolfes L; Ruck T; Beuker C; Schmidt-Pogoda A; Lohmann L; Schneider-Hohendorf T; Hahn T; Schwab N; Minnerup J; Melzer N; Klotz L; Meuth SG; Meyer Zu Hörste G; Baranzini SE; Wiendl H
    Brain; 2021 Oct; 144(9):2625-2634. PubMed ID: 33848319
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Retracted: Hypocretin (orexin) cell transplantation diminishes narcoleptic-like sleep behavior in rats.
    Arias-Carrión O; Drucker-Colín R; Murillo-Rodríguez E
    CNS Neurol Disord Drug Targets; 2012 Nov; ():. PubMed ID: 23131161
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Sleep and neurological diseases.
    Autret A
    J Neurol; 1997 Apr; 244(4 Suppl 1):S1-2. PubMed ID: 9112581
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.